# A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery

> **NCT02356588** · PHASE3 · COMPLETED · sponsor: **Talphera, Inc** · enrollment: 161 (actual)

## Conditions studied

- Post-Operative Pain

## Interventions

- **DRUG:** Sufentanil Tablet 30 mcg
- **DRUG:** Placebo Tablet

## Key facts

- **NCT ID:** NCT02356588
- **Lead sponsor:** Talphera, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-08
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2017-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02356588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02356588, "A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02356588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*